Broccoli Sprout Extract for Cognitive Function

Last updated: January 11, 2026
Sponsor: Pusan National University Yangsan Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Dementia

Memory Loss

Alzheimer's Disease

Treatment

Placebo Control

Broccoli sprout extract (BSE)

Clinical Study ID

NCT07334366
12-2024-018
  • Ages 50-85
  • All Genders

Study Summary

This clinical trial aims to determine whether broccoli sprout extract improves cognitive function in adults with mild cognitive impairment and to assess its safety.

The main questions are:

  • Does broccoli sprout extract improve cognitive function in participants?

  • What side effects occur when participants take broccoli sprout extract?

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Age: Adults aged 55-85 years (inclusive), both male and female

  • Global Deterioration Scale (GDS) score of 2-3:

GDS 2: Subjective memory impairment without objective evidence GDS 3: Mild objective memory impairment

  • Absence of dementia according to established diagnostic criteria

  • Ability to read Korean

Exclusion

Exclusion Criteria:

  • Severe medical conditions within the past 6 months: History of severecerebrovascular disease (cerebral infarction, cerebral hemorrhage), cardiac disease (angina, myocardial infarction, heart failure, arrhythmia requiring treatment), ormalignancy (Note: Participants with a history of cerebrovascular or cardiac diseasewho are clinically stable may be included at the investigator's discretion)

  • Cognitive impairment-associated diseases: Dementia, Parkinson's disease, cerebralinfarction, or other conditions associated with cognitive decline Uncontrolledhypertension: Blood pressure ≥160/100 mmHg (measured after 10 minutes of rest)

  • Poor glycemic control: Fasting blood glucose ≥160 mg/dL in diabetic patients

  • Uncontrolled thyroid dysfunction: Currently receiving treatment for uncontrolledhypothyroidism or hyperthyroidism

  • Renal impairment: Serum creatinine ≥2 times the upper limit of normal for theinstitution

  • Hepatic impairment: AST or ALT ≥2 times the upper limit of normal for theinstitution

  • Severe gastrointestinal symptoms: Complaints of severe heartburn, dyspepsia, orother gastrointestinal distress

  • Medications affecting cognitive function within the past month: Use of drugs (antipsychotics, anti-degenerative agents, cognitive enhancers, tricyclicantidepressants, hormone replacement therapy) or health functional foods that mayinfluence cognitive function due to dementia or other cognitive abnormalities

  • Other clinical trial participation: Participation in other drug clinical trialswithin the past month or planned participation during the study period

  • Alcohol use disorder, severe

  • Food allergies: Known allergic reactions to study product components

  • Investigator discretion: Any other condition deemed inappropriate for studyparticipation by the investigator

Study Design

Total Participants: 100
Treatment Group(s): 2
Primary Treatment: Placebo Control
Phase:
Study Start date:
April 16, 2025
Estimated Completion Date:
December 31, 2026

Study Description

Researchers will compare broccoli sprout extract to a placebo to evaluate their effectiveness in improving cognitive function in participants.

Participants will:

  • Take dietary broccoli sprout extract or a placebo daily for 12 weeks.

  • Visit the clinic at screenig, 0, 6, and 12 weeks for checkups and tests

Connect with a study center

  • Pusan National University Yangsan Hospital

    Yangsan 1832828, 50612
    South Korea

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.